Hey Jul,

The abstract is all that's been published so far.  I did present a much more informative poster presentation (equivalent to a 4 foot by 6 foot slide) at the AAN Annual Meeting last April and it was well received.

The statement "Mr. Batcheller has nothing to disclose." basically says neither big pharma, one of the vitamin manufacturers or any other company/corporation paid me to say anything.  In other words, the data is unbiased by any external interests or influences.  The way it should be.

Moreover, the cost of the abstract submission, printing the poster, round trip air fare from Seattle to Philadelphia, three nights of room, meals and cab fare came out of my pocket...

I'll be submitting the final manuscript for publication in a few weeks.  Not sure which of the neurology journals is going to print it... but I'll get it printed one way or another.

In the mean time I'll be happy to send a pdf copy of the draft manuscript to any CH'er who needs it to convince a neurologist to take interest... 

I can say that Dr. Todd Rozen, MD, who heads the Headache Center at the Geisinger Neurosciences Institute, Wilkes-Barre, PA, tolls me in April that he's been treating his chronic CH patients with vitamin D3 for over a year...  He's seeing the same response rate...

Take care,

V/R, Batch